Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,726–3,750 of 7,816 matching trials · page 150 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery NCT01592552 Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Sanguine Biosciences INDUSTRY |
2023-11-22 |
|
Video Games Therapy on Balance and Cognitive Functions in Mild to Moderate Impaired Multiple Sclerosis Patients. NCT03353974 Video game therapy; Balance platform therapy Runs in: Italy · 2 sites |
NA other |
COMPLETED | 48 | University Hospital of Ferrara OTHER |
2023-11-22 |
|
Brain Stimulation for Neurological Patients NCT03770182 NEUROLITH Runs in: Austria · 1 site |
NA other |
COMPLETED | 60 | Storz Medical AG INDUSTRY |
2023-11-22 |
|
A Mixed Method Pilot Study for Patients With Mild Cognitive Impairment and Insomnia. NCT04635085 Empowerment-based Cognitive behavioral therapy for insomnia for MCI Runs in: Hong Kong · 1 site |
NA other |
COMPLETED | 60 | The University of Hong Kong OTHER |
2023-11-22 |
|
Transdermal Trigeminal Electrical Neuromodulation on Mild Cognitive Impairment With Insomnia NCT05200897 Transdermal trigeminal electrical neuromodulation(Cefaly) Runs in: South Korea · 1 site |
NA other |
UNKNOWN | 60 | Saint Vincent's Hospital, Korea OTHER |
2023-11-22 |
|
The Effect of Auditory Interventions on Anxiety and Agitation in People With Dementia NCT05844241 Music and Theta Auditory Beat Stimulation; Audiobooks Runs in: Canada · 1 site |
NA other |
COMPLETED | 48 | Lucid, Inc. INDUSTRY |
2023-11-22 |
|
A Phase 3 Study of NE3107 in Probable Alzheimer's Disease NCT04669028 NE3107; Placebo Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 439 | BioVie Inc. INDUSTRY |
2023-11-21 |
|
SilverBills: A Financial and Legal Tech Tool for Caregivers NCT05382949 SilverBills Financial and Legal Tech Tool for Caregivers Runs in: United States · 1 site |
NA other |
UNKNOWN | 150 | Marci Lobel-Esrig OTHER |
2023-11-21 |
|
[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease NCT06141356 [18F]Florbetazine ([18F]92); [11C]PIB Runs in: China · 1 site |
NA other |
UNKNOWN | 150 | Peking Union Medical College Hospital OTHER |
2023-11-21 |
|
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder NCT01631851 Cognitive-Behavioral Therapy (CBT) for Irritability Runs in: United States · 1 site |
NA other |
COMPLETED | 9 | Yale University OTHER |
2023-11-18 |
|
Cognitive-Behavioral Therapy for Disruptive Behavior in Children and Adolescents NCT01965184 Cognitive-Behavioral Therapy for Anger and Aggression; Supportive P... Runs in: United States · 1 site |
NA other |
COMPLETED | 101 | Yale University OTHER |
2023-11-18 |
|
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study NCT02488720 Runs in: United States · 40 sites |
NA other |
COMPLETED | 538 | University of Southern California OTHER |
2023-11-18 |
|
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study NCT02850146 18F-AV-1451 Runs in: United States · 7 sites |
PHASE1 other |
COMPLETED | 55 | University of Southern California OTHER |
2023-11-18 |
|
Genomic Outcomes of Metformin NCT02986659 Metformin; Placebo Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 30 | Wake Forest University Health Sciences OTHER |
2023-11-18 |
|
Living Alone in Old Age With Cognitive Impairment NCT03330587 Runs in: United States · 1 site |
NA other |
UNKNOWN | 60 | University of California, San Francisco OTHER |
2023-11-18 |
|
Care Ecosystem: Navigating Patients and Families Through Stages of Care, Extension Trial NCT04287738 Navigated Care |
NA other |
COMPLETED | 912 | University of California, San Francisco OTHER |
2023-11-18 |
|
Impact of the Eurékoi Serious Game on Family Caregivers of Patients With a Major Neurocognitive Disorder NCT04573985 Serious game Eurekoi intervention Runs in: France · 1 site |
NA other |
COMPLETED | 40 | Centre Hospitalier Universitaire de Nice OTHER |
2023-11-18 |
|
Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of TB006 in Participants With Alzheimer's Disease NCT05074498 TB006; Placebo Runs in: United States · 18 sites |
PHASE1|PHASE2 other |
COMPLETED | 154 | TrueBinding, Inc. INDUSTRY |
2023-11-18 |
|
Effectiveness and Cost-Effectiveness of Robot Therapy With the Paro Robot in People Living With Dementia NCT05884424 PARO Therapy Robot Runs in: Spain · 15 sites |
NA other |
COMPLETED | 123 | Instituto de Mayores y Servicios Sociales (IMSERSO) OTHER_GOV |
2023-11-18 |
|
Effect of Time-restricted Eating on Cognitive Function and Other Biopsychosocial Factors in Menopausal Women Undertaking a 12-week Exercise Programme NCT06138015 Exercise and Time-Restricted Eating; Exercise only Runs in: Poland · 1 site |
NA other |
COMPLETED | 80 | Poznan University of Physical Education OTHER |
2023-11-18 |
|
Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients NCT03417583 Protocol Intervention Group Runs in: United States · 1 site |
NA other |
COMPLETED | 100 | Vanderbilt University Medical Center OTHER |
2023-11-15 |
|
Safe & Easy for Alzheimer's Disease and Related Pathologies NCT02518243 Patient's answer with non pharmacological therapeutic Runs in: France · 1 site |
NA other |
COMPLETED | 7 | Centre Hospitalier Universitaire de Nice OTHER |
2023-11-14 |
|
Identification of Early Markers of Alzheimer's Disease by Using Eye Tracking in Reading. NCT02557464 An eye tracking experiment; A neuropsychological evaluation Runs in: France · 1 site |
NA other |
COMPLETED | 14 | Centre Hospitalier Universitaire de Nice OTHER |
2023-11-14 |
|
A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type NCT03594123 Brexpiprazole; Brexpiprazole Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 259 | Otsuka Pharmaceutical Development & Commercialization, Inc. INDUSTRY |
2023-11-14 |
|
Lifestyle Remodeling in Subjective Memory Complaint (SMC): Brain Imaging and Blood Biochemistry Study NCT04162990 Lifestyle remodeling Intervention; Does Comparator: regular treatment Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 50 | Taipei Veterans General Hospital, Taiwan OTHER_GOV |
2023-11-14 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial